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ABSTRACT
Avian mycobacteriosis is important for animal and human health; wild birds play an
important role in mycobacterial species’ ecology and movement. This review was
aimed at reporting the role of birds in the spread of avian mycobacteriosis in human
and animal populations at risk and thus a systematic review was made of PubMed,
Science Direct, Scielo and Scirus databases. Mycobacteria are classified into the
Mycobacterium tuberculosis complex and non-tuberculous mycobacteria; the
Mycobacterium avium complex represents the most important part of the latter because
it is primarily responsible for mycobacterial infection in wild birds and is a potential
pathogen for mammals, especially for immunocompromised patients. The clinical
signs in birds are variable as it is a chronic and debilitating disease, involving emaciated
carcasses, white nodules in different organs and microscopically it presents
granulomatosous multifocal inflammation. Diagnosis begins by suspicion based on
clinical signs and finishes with microbiological confirmation. New diagnostic techniques
include testing with DNA-RNA probes. No effective treatment is currently available and
chemoprophylaxis on suspicion of infection is not recommended at the start; these
factors increase the potential risk of mycobacteriosis becoming one of the most
frequently documented zoonotic diseases which is difficult to treat in birds and humans.
Recent concern regarding mycobacterial infection lies in the increased frequency of
these opportunistic infections occurring in immunocompromised individuals and these
infections’ potential impact on bird conservation, this being increased by greater contact
between humans and wild and captive birds.
Key Words: Atypical Mycobacterium infection, wild animal, bird (source: MeSH, NLM).
RESUMEN
La micobacteriosis aviar es de importancia para la salud animal y humana. El objetivo
de esta revisión fue reportar el papel de las aves en la diseminación de la
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micobacteriosis aviar en poblaciones vulnerables. Se realizó una revisión sistemáti-
ca en las bases de datos PubMed, Science Direct, Scielo and Scirus. Las aves silves-
tres juegan un papel importante en la ecología y movimiento de micobacterias. Estas
se clasifican en el Complejo Mycobacterium tuberculosis y las micobacterias no
tuberculosas, dentro de este último grupo se destaca el Complejo Mycobacterium
avium, principal responsable de micobacteriosis en aves silvestres y patógeno po-
tencial para los mamíferos principalmente pacientes inmunosuprimidos. Los signos
clínicos son variables, siendo una enfermedad debilitante y crónica, e involucra
carcasas emaciadas, nódulos blanquecinos en diferentes órganos,
microscópicamente presenta inflamaciones granulomatosas multifocales. El diag-
nóstico inicia por la sospecha basada en los síntomas clínicos y termina con la
confirmación microbiológica. Adicionalmente, las nuevas técnicas diagnósticas in-
cluyen pruebas con sondas de ADN-ARN. Actualmente, no existe un tratamiento efec-
tivo y no se recomienda iniciar quimioprofilaxis; estos factores incrementan el riesgo
potencial para convertir la micobacteriosis aviar en una enfermedad zoonótica más
frecuente de lo documentado y de difícil tratamiento en aves y humanos. La reciente
preocupación de las infecciones micobacterianas, radica en el aumento de la fre-
cuencia de estas infecciones oportunistas en personas inmunocomprometidas y el
impacto potencial de estas infecciones sobre la conservación de las especies de
aves, favorecido por el mayor contacto entre humanos y aves tanto silvestres como
cautivas.
Palabras Clave: Infecciones atípicas por Mycobacterium, animales salvajes, aves
(fuente: DeCS, BIREME).
healthy birds; such birds could play a significant role in microorganism ecology and
migration (1,3). The efficiency of microorganism dispersion depends on both biotic
(i.e. vertebrate host or invertebrate vector susceptibility and the persistence of
agents in the environment) and abiotic factors (i.e. temperature and humidity affecting
the agents’ survival or their becoming scattered from habitats or ecosystems into
new geographical areas) (1-3).
The current status of avian mycobacteriosis in nature or in captivity is hardly
known, nor is their dispersion by bird species in Latin-America. This article reports
the role of birds regarding the potential risk of infectious diseases (e.g. avian
mycobacteriosis) becoming disseminated for vulnerable populations such as those
infected by human immunodeficiency virus (HIV), and other chronic and debilitating
diseases such as cancer, diabetes, lupus and those of extreme ages such as children
and old people who are predisposed ipso facto to infection by mycobacteria.
Birds can become involved in the dispersal of microorganisms as biologicaland mechanical carriers or become infected with blood ectoparasites (1,2).Many vertebrate’s pathogenic microorganism species are associated with
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A systematic search of the PubMed, Science Direct, Scielo and Scirus databases
was thus made using the following words in all possible MeSH (Medical Subject
Heading) term combinations: avian mycobacteriosis, avian tuberculosis,
Mycobacterium infection, M. avium complex and wild birds. This was
complemented by reviewing wildlife medicine reference books. Articles published
from 1975 to 2007 were selected which reported generalities regarding
mycobacteria in wild birds, their clinical characteristics and diagnosis and importance
in animal and human health.
Mycobacteria and wild animals
Mycobacteria are acid-fast bacilli, acidophilic, small and slightly curved. They are
aerobic, immobile and non-sporulated bacteria. Their cell wall is lipid-rich, forming
smooth to wrinkled colonies when cultured in solid medium; some are pigmented
(3,4). Their high concentration in lipid cells is responsible for their resistance to
immune system defence mechanisms and disinfectants (3,5). Mycobacterium
tuberculosis complex species are recognised as being the cause of tuberculosis in
mammals, although M. tuberculosis and M. bovis have been reported in birds and
other species (3,4). Another important group in human and veterinary medicine
consists of non-tuberculous mycobacteria (NTM), these being opportunistic
saprophytes causing mycobacteriosis in animals (Table 1) (3-6).
Table 1. Mycobacterial species and the wild hosts affected by them
The M. avium complex (MAC) consists of opportunistic pathogens capable of
causing disease in animals and humans (4,7). MAC has 28 serotypes from M.
avium and M. intracellulare species (7-9). Serotype 1 is most frequently reported
in North-American birds whilst serotype 2 is more commonly reported in Europe.
Serotype 3 has been sporadically isolated in European birds and 2 and 3 are more
highly pathogenic than serotype 1. Serotypes 1, 4 and 8 are most frequently isolated
from humans (11).
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Several types of mycobacterial disease occur in vertebrates. Mycobacteria
cause disease in mammals, birds, reptiles, amphibians and fish (Table 1) (2,13-17);
they are considered to be globally distributed and occur only occasionally due to the
few studies published so far (14).
Avian mycobacteriosis
Three types of lesion are caused by mycobacteria in birds: the tubercular, focal or
multifocal form, the disseminated or diffuse form and the paratuberculous form in
the gastrointestinal tract (11,19). Its clinical presentation varies greatly, thereby
hampering ante-mortem diagnosis (20).
MAC (and more recently M. genavense) is the mycobacteria which has been
most commonly isolated from domestic and wild birds and humans (Table 1)
(10,13,15,20,21,22). Some zoos have set up avian mycobacterial collections of
valuable specimens catalogued as being rare or in danger of extinction. The cost of
replacing such valuable animals thus emphasises the importance of these
mycobacterial species’ timely diagnosis (9,11,14,16,17,26,27).
Epidemiology
Distribution
Avian mycobacteriosis is a worldwide disease affecting all birds, whether living
free or in captivity in one form or another (2,9,12,20,29,30). This disease occurs
most commonly in temperate zones in northern and tropical areas; mycobacteriosis
is not usually reported in tropical areas and has been poorly investigated. Its distribution
in healthy wild birds is inferred from birds sent for necropsy; however, sampling
underestimates the geographical distribution and frequency of species’ infection
(12,30).
Incidence and prevalence
Mycobacterial infection incidence in birds remains unknown and varies depending
on the species, age, housing conditions and whether birds are living in captivity or
the wild. The incidence detected during avian necropsy has ranged from 0.5% to
14% (21,25,31,32). Mycobacterial infection prevalence in wild birds has not been
determined, although usually at least 1 per cent of birds examined postmortem are
affected. Some authors have stated that mycobacterial infections have a more
important effect on captive birds than wild ones (12).
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Susceptible species
Avian mycobacteriosis has been reported in many species of birds (17,24,25,33,34),
but MAC and M. genavense are also potential pathogens for mammals, particularly
if they are immunosuppressed (2,12,13,15,19).  Mycobacterial infection has been
reported in parrots (11,19,25,35), raptors (2,9,19,22,23,25,27,29, 31,36-38), doves
and pigeons (2, 19, 28, 39), cranes (27,33,34,36,40,41), musofagides and ratites
(42,43), ducks (11,26,44), songbirds (11,26), toucans (45), flamingos (46-49) and
turkeys (21).
It is rare to see mycobacterial infection in birds aged less than 2; the disease is
more common in poultry and older aquatic species due to the microorganism’s long
incubation period, the cumulative risk of exposure and decreased immune response.
Peak incidence in parrots has been reported as being 3 to 10 years of age (1,20,25).
For unknown reasons, females appear to be more commonly infected than males
in postmortem surveillance and clinical reports (25). Another factor influencing
susceptibility to infection is the type of mycobacteria involved; some are more
pathogenic to some other bird species (25).
Susceptibility to mycobacterial infection in humans is closely related to the immune
response, as a poor host immune response to mycobacteria may lead to replication
thereby causing infection and illness (1,15,25,50). Although the host responds
appropriately and controls mycobacterial infection, it does not necessarily resolve
it. Mycobacteria living within macrophages in the host have replicated at subclinical
levels for years to develop the active infection when the host’s immune system is
less efficient or has been immunocompromised (1,15,25).
Transmission
Avian mycobacteriosis is often associated with areas having high animal
concentrations and/or a contaminated environment; such areas where birds are
congregated should be recognised as potential danger spots as such conditions are
more common in captive birds (25,34). It is mainly transmitted by inhaling and
ingesting contaminated food or water (3,11,12,14,21, 22,25,31,36) when infected
adults are feeding with their young and/or direct contact with infected birds’ bodily
excretions or carcasses (3,10,11,12,14,21,25).
Clinical signs
The signs of infection in birds are variable and non-specific during infection or
disease and may pass unnoticed, thereby hampering its diagnosis in live birds (25,
23, 29, 33, 51). Mycobacterial infection should be suspected in birds suffering
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chronically debilitating disease, although it should also be considered in acute deaths
(11,12,21,23,25,26,44,48,52). Death occurs after progressive weight-loss and mus-
cular atrophy (11,23,27,29,34,52). Affected animals generally exhibit signs of
depression, weakness, anorexia and fever (12,17,22,25). There may also be diarrhoea,
polyuria, arthritis, claudication, pathological fractures, ascites and subcutaneous
tumours (11,12,23,25).
Clinical pathology
Polycromasy is most consistently observed (with or without anaemia) (25). Persistent
lymphopenia has also been reported; this is regarded as being an indicator of
advanced mycobacterial infection but a normal lymphocyte count does not exclude
a diagnosis of disseminated mycobacterial infection (29,52) and may be concurrent
with eosinophilic monocytosis by granulomatous inflammation. Thrombocytosis has
been reported but has been very diverse (50% in domestic birds but only 6% in
cranes) (25,29,52). Hypoalbuminaemia caused by gastrointestinal loss and decreased
hepatic production may be present (25,29). Hepatic enzyme values may be abnormal
in birds having marked hepatomegally (25).
Macroscopic findings
Primary lesion location indicates the exposure route; intestinal lesions suggest
mycobacterial intake in contaminated food and water whilst lesions in the lungs and
other areas of the respiratory tract suggest inhalation as being the exposure route
(12). Typical cases of avian mycobacteriosis in wild birds involve lack of subcutaneous
and mesenteric fat accompanied by severe atrophy of pectoral muscle, characteristic
white, gray or yellow nodules and hepatosplenomegally (12,21,27,29,34,41,48,52).
Granulomatous lesions may be found in the lungs, spleen, intestines, bone marrow,
heart, gonads, skin and joints (hepatic lesions predominating) (3,9,11,12,14,20-23,25,27-
29,36,37,40,48,52,53). Unusual lesions have included necrotic ulceration of the tongue
and chronic granulomatous lesions located in the dermis around the nostrils and
retro-orbital and sinus infraorbitary tissues (11,12,20,29,37).
Microscopic findings
Lesions appear as a focus of epitheloid cells (macrophages) early in the course of
the disease. Because the disease is progressive, tubers are often characterised by
a well-defined area of central necrosis surrounded by a capsule (9,17,22,23,40).
Multifocal granulomatous inflammation is severe and multifocal, with acidophilus
bacilli within lesions (20,21,26,27,29,34, 38,41,42,46).
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Diagnosis
Ante-mortem diagnosis is based on clinical signs, leukograme, serology, culture and
resistant acid alcohol stain or biopsy samples of animal fluids or organs (11,19,25,29,37).
Radiography, ultrasonography and coelomoscopy are useful in the medical evaluation
of birds (25,29).
The benchmark test for diagnosing mycobacterial disease is bacterial growth in
culture (53). However, this delays its clinical usefulness in many situations because
the culture is not available in less than two weeks and some species, such as M.
genavense, are difficult to isolate by standard culture techniques (24,32,51,54).
The enzymatic linked immunoassay (ELISA) has been used for detecting
antimycobacterial antibodies in the serum of certain species having clinical
significance (9,17,42). New techniques include diagnostic deoxyribonucleic acid-
ribonucleic acid (DNA-RNA) and polymerase chain reaction (PCR) tests for
specific mycobacterial genes (9,10,11,13,15,20,21,25,28,29). Polymorphism restriction
analysis (PRA) is used for identifying mycobacterial species and subspecies
(8,10,42,55). Another DNA cleavage technique involves pulsed-field gel
electrophoresis which identifies subspecies within a group. Sequencing the organism
is also important (42).
Treatment, control and prevention
No studies were found showing that treatment has been effective and initiating
chemoprophylaxis therapy is not recommended because mycobacteria are highly
resistant to antibiotics (11,14,23,29). Moreover, there is the risk of creating resistance
in potentially zoonotic mycobacteria, especially if the species involved are not known
(17,26,50).
Affected individuals’ euthanasia is the most frequent recommendation. (11,12,18).
Controlling the disease is difficult; decreasing population density is recommended,
in addition to strict hygiene (26).
It must be ensured that animals purchased for zoo collections or colonies are
disease-free by using leukogrames, laparoscopy and measuring proteins (17,27).
Quarantine should be compulsory for new animals; the period should extend for a
minimum of 60 days (17). Vaccination is not an effective option as no vaccine is
available, nor has the matter been scientifically studied (1,20,56).
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Zoonotic potential
The risk of NTM being transmitted to immunocompetent adult humans appears to
be extremely small (7, 8,11,12,32). However, there is a significant risk of transmission
to children and immunocompromised individuals. Humans receiving steroid therapy,
chemotherapy or other immunosuppressive medication and patients infected with
HIV, AIDS or leukaemia should be carefully considered regarding their possession
or coming into contact with birds proving positive for mycobacterial infection.
Preventative measures should be taken regarding visiting national parks and zoos
(12,25,37,57). Several clinical manifestations of avian mycobacteriosis occur in
human patients (7,10,11). Treating avian mycobacteriosis in humans has had limited
success because NTM are resistant to antituberculous drugs. The clinical signs,
diagnosis and treatment of NTM infection in humans have been described previously
(7,11).
Conclusions
Information regarding mycobacterial infection in birds is relatively limited and
incomplete. This is due to a lack of information about the apparently long incubation
period, inadequate proof of identification, difficulty in detecting infected birds, the
broad spectrum of disease signs in birds and a lack of funding (the disease is not
considered economically significant within a veterinarian context) (12,16).
Recent advances in identifying mycobacterial species have led to improved
diagnosis and determining which species may be causing avian disease. The usual
methods for identifying Mycobacterium species have been based on their
bacteriological characteristics; however, biochemical tests are not accurate for
these species’ phenotypic differentiation and most laboratories have reported isolating
at least one member of the MAC. Using PCR and sequencing bird samples is
important as culturing is very slow in terms of clinical usefulness in many situations
and a faster diagnostic test having similar or greater sensitivity is needed and M.
genavense is a relatively common pathogen in birds but does not grow on
conventional media (8,24,51,54,58).
The recent concern about diagnosing and treating mycobacterial infections has
resulted from opportunistic mycobacterial infections occurring in AIDS patients
(7,57,59). Increasing contact between humans and wildlife, either in captivity when
visiting zoos or having wildlife as pets (which is unsuitable) or in the wild with the
rise of ecotourism and increasing colonisation of wilderness areas has thereby led
to increasing contact between wild animals and humans and the subsequent
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transmission and spread of pathogens (30). For example, an estimated 33.2 million
people worldwide are living with HIV/AIDS, 2.5 million of whom are children
under 15 years old; 1.6 million of these adults and children are living in Latin-
America (59). On the other hand, it is estimated that 24.6 million people are living
with lung, breast and colorectal cancer (three year diagnosis) (60). They would
thus be examples of human populations at risk of contracting this type of disease by
coming into close contact with wildlife ♦
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